BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24927658)

  • 1. [Radiological diagnostics of multiple myeloma].
    D'Anastasi M; Grandl S; Reiser MF; Baur-Melnyk A
    Radiologe; 2014 Jun; 54(6):556-63. PubMed ID: 24927658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of whole body magnetic resonance imaging (WBMRI) to whole body computed tomography (WBCT) or
    Gariani J; Westerland O; Natas S; Verma H; Cook G; Goh V
    Crit Rev Oncol Hematol; 2018 Apr; 124():66-72. PubMed ID: 29548488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multiple myeloma: current recommendations for imaging].
    Hillengass J; Delorme S
    Radiologe; 2012 Apr; 52(4):360-5. PubMed ID: 22441560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI).
    Gleeson TG; Moriarty J; Shortt CP; Gleeson JP; Fitzpatrick P; Byrne B; McHugh J; O'Connell M; O'Gorman P; Eustace SJ
    Skeletal Radiol; 2009 Mar; 38(3):225-36. PubMed ID: 19009290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma.
    Westerland O; Amlani A; Kelly-Morland C; Fraczek M; Bailey K; Gleeson M; El-Najjar I; Streetly M; Bassett P; Cook GJR; Goh V;
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2558-2565. PubMed ID: 33469686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
    Dammacco F; Rubini G; Ferrari C; Vacca A; Racanelli V
    Clin Exp Med; 2015 Feb; 15(1):1-18. PubMed ID: 25218739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging of neuroendocrine tumours: comparison of [⁶⁸Ga]DOTATOC multiphase PET/CT and whole-body MRI.
    Schraml C; Schwenzer NF; Sperling O; Aschoff P; Lichy MP; Müller M; Brendle C; Werner MK; Claussen CD; Pfannenberg C
    Cancer Imaging; 2013 Mar; 13(1):63-72. PubMed ID: 23466785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
    Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.
    Zamagni E; Nanni C; Patriarca F; Englaro E; Castellucci P; Geatti O; Tosi P; Tacchetti P; Cangini D; Perrone G; Ceccolini M; Brioli A; Buttignol S; Fanin R; Salizzoni E; Baccarani M; Fanti S; Cavo M
    Haematologica; 2007 Jan; 92(1):50-5. PubMed ID: 17229635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body magnetic resonance imaging (WBMRI) versus whole-body computed tomography (WBCT) for myeloma imaging and staging.
    Treitl KM; Ricke J; Baur-Melnyk A
    Skeletal Radiol; 2022 Jan; 51(1):43-58. PubMed ID: 34031705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging in multiple myeloma.
    Delorme S; Baur-Melnyk A
    Eur J Radiol; 2009 Jun; 70(3):401-8. PubMed ID: 19272726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Imaging in smoldering (asymptomatic) multiple myeloma. Past, present and future].
    Bhutani M; Landgren O
    Radiologe; 2014 Jun; 54(6):572, 574-81. PubMed ID: 24927659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body MRI and PET/CT in multiple myeloma patients during staging and after treatment: personal experience in a longitudinal study.
    Cascini GL; Falcone C; Console D; Restuccia A; Rossi M; Parlati A; Tamburrini O
    Radiol Med; 2013 Sep; 118(6):930-48. PubMed ID: 23801394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
    Iagaru A; Young P; Mittra E; Dick DW; Herfkens R; Gambhir SS
    Clin Nucl Med; 2013 Jul; 38(7):e290-6. PubMed ID: 23455520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative diagnostic performance of ¹⁸F-FDG PET/CT versus whole-body MRI for determination of remission status in multiple myeloma after stem cell transplantation.
    Derlin T; Peldschus K; Münster S; Bannas P; Herrmann J; Stübig T; Habermann CR; Adam G; Kröger N; Weber C
    Eur Radiol; 2013 Feb; 23(2):570-8. PubMed ID: 22843058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging in myeloma: a Royal College of Radiologists national survey of current imaging practice.
    Westerland O; Drinkwater KJ; Parikh J; Streetly M; Pratt G; Goh V; Howlett DC
    Clin Radiol; 2021 Nov; 76(11):820-828. PubMed ID: 34187681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.
    Mesguich C; Hulin C; Latrabe V; Lascaux A; Bordenave L; Hindié E; Marit G
    Ann Hematol; 2020 Dec; 99(12):2869-2880. PubMed ID: 32951093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [PET-CT for nuclear medicine diagnostics of multiple myeloma].
    Dimitrakopoulou-Strauss A
    Radiologe; 2014 Jun; 54(6):564, 566-71. PubMed ID: 24890842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI].
    Pfannenberg C; Schwenzer N
    Radiologe; 2015 Feb; 55(2):120-6. PubMed ID: 25589421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.